Pyxis Oncology (PYXS) Total Liabilities (2020 - 2026)

Pyxis Oncology (PYXS) has reported Total Liabilities for 7 consecutive years, with $43.5 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Total Liabilities rose 22.24% year-over-year to $43.5 million in Q2 2026; TTM through Jun 2026 was $43.5 million, a 22.24% increase from a year earlier, with the FY2025 full-year figure at $38.1 million, up 4.62% from the prior year.
• Total Liabilities was $43.5 million for Q2 2026 at Pyxis Oncology, up from $38.1 million in the prior quarter.
• Over five years, Total Liabilities peaked at $50.6 million in Q4 2022 and troughed at $19.2 million in Q1 2022.
• A 5-year average of $37.2 million and a median of $36.4 million in 2024 frame the typical range for Total Liabilities.
• The widest YoY moves for Total Liabilities: up 170.23% in 2022, down 61.64% in 2022.
• Over 5 years, Total Liabilities stood at $50.6 million in 2022, then retreated by 5.01% to $48.0 million in 2023, then decreased by 24.14% to $36.4 million in 2024, then grew by 4.62% to $38.1 million in 2025, then advanced by 14.09% to $43.5 million in 2026.
• The last three Total Liabilities figures came in at $43.5 million (Q2 2026), $38.1 million (Q4 2025), and $36.8 million (Q3 2025), per Business Quant data.